671 related articles for article (PubMed ID: 22182353)
1. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.
Brouquet A; Nordlinger B
Scand J Gastroenterol; 2012 Mar; 47(3):286-95. PubMed ID: 22182353
[TBL] [Abstract][Full Text] [Related]
2. [Specific treatment situations in metastatic colorectal cancer].
Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
[TBL] [Abstract][Full Text] [Related]
3. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
Benoist S; Nordlinger B
Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy with curative intent before (neoadjuvant) or after (adjuvant) surgery for colorectal cancer liver metastases].
Rougier P; Guimbaud R; Mitry E; Vaillant JN
Bull Acad Natl Med; 2003; 187(5):881-92. PubMed ID: 14979053
[TBL] [Abstract][Full Text] [Related]
5. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
Reddy SK; Tsung A; Marsh JW; Geller DA
J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant therapy after resection of colorectal cancer liver metastases.
Power DG; Kemeny NE
J Clin Oncol; 2010 May; 28(13):2300-9. PubMed ID: 20368552
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer metastases: surgical indications and multimodal approach.
Ciferri E; Bondanza GS; Municinò O; Castagnola M; Gazzaniga GM
Hepatogastroenterology; 2003; 50(54):1836-46. PubMed ID: 14696416
[TBL] [Abstract][Full Text] [Related]
8. [Colorectal cancer liver metastases -- neoadjuvant concepts for preoperative down-sizing].
Golling M; Gog C; Woeste G; Zapletal C; Wullstein C; Bechstein WO
Zentralbl Chir; 2006 Apr; 131(2):140-7. PubMed ID: 16612781
[TBL] [Abstract][Full Text] [Related]
9. Trials on preoperative chemotherapy in resectable colorectal liver metastases need prospective evaluation of predictive factors of response.
Nasti G; Ottaiano A; Rosario Iaffaioli V; Berretta M; Delrio P
J Clin Oncol; 2008 Aug; 26(22):3812-3; author reply 3813. PubMed ID: 18669474
[No Abstract] [Full Text] [Related]
10. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
Alberts SR; Horvath WL; Sternfeld WC; Goldberg RM; Mahoney MR; Dakhil SR; Levitt R; Rowland K; Nair S; Sargent DJ; Donohue JH
J Clin Oncol; 2005 Dec; 23(36):9243-9. PubMed ID: 16230673
[TBL] [Abstract][Full Text] [Related]
11. [Radiofrequency ablation of colorectal liver metastases].
Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative chemotherapy for colorectal cancer liver metastases: an update of recent clinical trials.
Nasti G; Ottaiano A; Berretta M; Delrio P; Izzo F; Cassata A; Romano C; Facchini G; Scala D; Mastro A; Romano G; Perri F; Iaffaioli RV
Cancer Chemother Pharmacol; 2010 Jul; 66(2):209-18. PubMed ID: 20333385
[TBL] [Abstract][Full Text] [Related]
13. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials.
Brouquet A; Nordlinger B
J Surg Oncol; 2010 Dec; 102(8):932-6. PubMed ID: 21165995
[TBL] [Abstract][Full Text] [Related]
15. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients.
Coskun U; Buyukberber S; Yaman E; Uner A; Er O; Ozkan M; Dikilitas M; Oguz M; Yildiz R; B DY; Kaya AO; Benekli M
Neoplasma; 2008; 55(1):65-70. PubMed ID: 18190244
[TBL] [Abstract][Full Text] [Related]
16. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
[TBL] [Abstract][Full Text] [Related]
17. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases.
Kingham TP; D'Angelica M; Kemeny NE
J Surg Oncol; 2010 Dec; 102(8):988-95. PubMed ID: 21166003
[TBL] [Abstract][Full Text] [Related]
18. [Hepatectomy for colorectal liver metastases after neoadjuvant chemotherapy].
Brouquet A; Benoist S
Bull Cancer; 2011 Jan; 98(1):11-8. PubMed ID: 21300602
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection.
Power DG; Kemeny NE
Crit Rev Oncol Hematol; 2011 Sep; 79(3):251-64. PubMed ID: 20970353
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma.
Leonard GD; Brenner B; Kemeny NE
J Clin Oncol; 2005 Mar; 23(9):2038-48. PubMed ID: 15774795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
